Day 2 :
Keynote Forum
Teddy Rothstein
Inventor, OJW Protocol, USA
Keynote: Providing Orthodontic Jaw Wiring Weight-Control (OJW®:Weight Control) as part of a “Healthcare Teamâ€â€”A new service in the dental professional’s office
Biography:
Teddy Rothstein practiced every phase of Orthodontic-Orthopedics for thirty-seven years, He moved from Brookyn, NY to Portland, OR in August ’16 where on Dec. 16, 2017. He petitioned the OR Board of Dentisty to sanction OJW for Dental Professionals. He await their decision. He invented the appliance and developed the protocol for providing OJW: Weight-control. He provide OJW in Brooklyn NY. He have treated 200 patients most of whom come from everywhere in the United States simply because he is the sole provider
Abstract:
My work demonstrates that Dental Professionals (DPs) are welcomed by the public and as providers of weight control services as part of a Healthcare team that includes dieticians, physicians, psychotherpists and baritric surgeons. OJW is a fixed intra-oral, bio-mechanical appliance and protocol for controlling compulsive overeating in carefully selected patients who are obese/heading toward obesity, that help them start regaining control over compulsive eating habits with potentially grave health consequences. Patients are wired into the physiologic rest position thereby limiting the extent they can open their jaw. Permission to begin a liquid diet is obtained from their physician. The clarity of speech is unaffected.
Seemingly extreme, after seventeen years providing OJW, it is arguably rather a benign non-invasive, safe and effective method, when using my protocol. Under my protocol, the DP is responsible for maintaining the health of the TMJ, dentition and gingiva. The patient is responsible for losing weight by dint of their passionate dedication and adherence to a long-term, low-calorie, liquid diet authorized by their physican or proxy (psychotherapist) with guidance from dietitians and nutritionists. Today I will enumerate the myriad consequences of obesity, and the DPs function as a member of a Healthcare team. I will describe the appliance and how-why it works. Then demonstrate how to wire the jaws and tell you about the position the jaw is wired into. I will outline the scope of the service . I will address safety and effectivness by referencing a questionnaire I mounted in 2009. Documents will include the informed consent, poor candidates, how to address problems, and a list of the ten most important elements of the OJW service
Keynote Forum
Teddy Rothstein
Inventor, OJW Protocol, USA
Keynote: Providing Orthodontic Jaw Wiring Weight-Control (OJW®:Weight Control) as part of a “Healthcare Teamâ€â€”A new service in the dental professional’s office
Time : 09:30-10:05
Biography:
Teddy Rothstein practiced every phase of Orthodontic-Orthopedics for thirty-seven years, He moved from Brookyn, NY to Portland, OR in August ’16 where on Dec. 16, 2017. He petitioned the OR Board of Dentisty to sanction OJW for Dental Professionals. He await their decision. He invented the appliance and developed the protocol for providing OJW: Weight-control. He provide OJW in Brooklyn NY. He have treated 200 patients most of whom come from everywhere in the United States simply because he is the sole provider
Abstract:
My work demonstrates that Dental Professionals (DPs) are welcomed by the public and as providers of weight control services as part of a Healthcare team that includes dieticians, physicians, psychotherpists and baritric surgeons. OJW is a fixed intra-oral, bio-mechanical appliance and protocol for controlling compulsive overeating in carefully selected patients who are obese/heading toward obesity, that help them start regaining control over compulsive eating habits with potentially grave health consequences. Patients are wired into the physiologic rest position thereby limiting the extent they can open their jaw. Permission to begin a liquid diet is obtained from their physician. The clarity of speech is unaffected.
Seemingly extreme, after seventeen years providing OJW, it is arguably rather a benign non-invasive, safe and effective method, when using my protocol. Under my protocol, the DP is responsible for maintaining the health of the TMJ, dentition and gingiva. The patient is responsible for losing weight by dint of their passionate dedication and adherence to a long-term, low-calorie, liquid diet authorized by their physican or proxy (psychotherapist) with guidance from dietitians and nutritionists. Today I will enumerate the myriad consequences of obesity, and the DPs function as a member of a Healthcare team. I will describe the appliance and how-why it works. Then demonstrate how to wire the jaws and tell you about the position the jaw is wired into. I will outline the scope of the service . I will address safety and effectivness by referencing a questionnaire I mounted in 2009. Documents will include the informed consent, poor candidates, how to address problems, and a list of the ten most important elements of the OJW service
Keynote Forum
Teddy Rothstein
Inventor, OJW Protocol, USA
Keynote: Providing Orthodontic Jaw Wiring Weight-Control (OJW®:Weight Control) as part of a “Healthcare Teamâ€â€”A new service in the dental professional’s office
Time : 09:30-10:05
Biography:
Teddy Rothstein practiced every phase of Orthodontic-Orthopedics for thirty-seven years, He moved from Brookyn, NY to Portland, OR in August ’16 where on Dec. 16, 2017. He petitioned the OR Board of Dentisty to sanction OJW for Dental Professionals. He await their decision. He invented the appliance and developed the protocol for providing OJW: Weight-control. He provide OJW in Brooklyn NY. He have treated 200 patients most of whom come from everywhere in the United States simply because he is the sole provider
Abstract:
My work demonstrates that Dental Professionals (DPs) are welcomed by the public and as providers of weight control services as part of a Healthcare team that includes dieticians, physicians, psychotherpists and baritric surgeons. OJW is a fixed intra-oral, bio-mechanical appliance and protocol for controlling compulsive overeating in carefully selected patients who are obese/heading toward obesity, that help them start regaining control over compulsive eating habits with potentially grave health consequences. Patients are wired into the physiologic rest position thereby limiting the extent they can open their jaw. Permission to begin a liquid diet is obtained from their physician. The clarity of speech is unaffected.
Seemingly extreme, after seventeen years providing OJW, it is arguably rather a benign non-invasive, safe and effective method, when using my protocol. Under my protocol, the DP is responsible for maintaining the health of the TMJ, dentition and gingiva. The patient is responsible for losing weight by dint of their passionate dedication and adherence to a long-term, low-calorie, liquid diet authorized by their physican or proxy (psychotherapist) with guidance from dietitians and nutritionists. Today I will enumerate the myriad consequences of obesity, and the DPs function as a member of a Healthcare team. I will describe the appliance and how-why it works. Then demonstrate how to wire the jaws and tell you about the position the jaw is wired into. I will outline the scope of the service . I will address safety and effectivness by referencing a questionnaire I mounted in 2009. Documents will include the informed consent, poor candidates, how to address problems, and a list of the ten most important elements of the OJW service
Biography:
Moses S S Chow graduated from University of California, San Francisco and currently is Professor of Pharmacy Practice at the College of Pharmacy, Western University of Health Sciences, Pomona, California. His previous academic appointments included Professor, University of Connecticut School of Pharmacy and Director, Chinese University of Hong Kong. He has supervised/co-supervised over 40 Master’s and PhD degree students and Post-doctoral fellows. He has published as author/co-author over 300 articles, book chapters, monographs in Pharmacokinetic Studies, Translational Research and Drug Development, including Chinese medicine. He has served as a Consultant to NIH and USPs as well as Visiting Professor to a number of pharmacy schools in Asia. He has served as Board Member and Secretary of the American College of Clinical Pharmacology, President of American Chinese Pharmaceutical Association and Founding President and Board member of Asian Association of Schools of Pharmacy (AASP)
Abstract:
Although more than 50% of anticancer drugs are originally derived from natural products, the use of herbal products as a systemic chemotherapeutic agent is not an accepted practice in Western countries since these products are not approved by regulatory agencies due to lack of definitive clinical efficacy studies. However, there is increasing evidence that a number of herbal products especially in combination with established anticancer drugs can significantly re-sensitize certain anticancer drugs via different mechanisms. Such activity offers new therapeutic potential of their use in cancer chemotherapy, especially for resistant cancer, which is responsible for the high cancer mortality globally. Various examples of herbal product that can exert different cytotoxic effects leading to enhanced activity when combined with conventional anticancer agents will be presented and the advantage of development of such combination products for therapeutic use will be discussed
Keynote Forum
Gian Carlo Tenore
University of Naples Federico II, Italy
Keynote: Nutraceuticals: Novel drugs for healthy people
Biography:
Gian Carlo Tenore graduated in 1999 in Medicinal Chemistry at the Department of Pharmacy, University "Federico II" of Naples. He received in 2003 the PhD degree in “Pharmacologically Active Natural Substances” at the Department of Pharmacy. He has been Research Assistant in Organic Chemistry, from 2003 to 2009, at the Department of Pharmacy. In 2009, he is designated as PhD Researcher and Assistant Professor of Food Chemistry at the Department of Pharmacy. In 2016, he is designated as Associate Professor of Food Chemistry and Scientific Responsible of the NutraPharmaLabsTM laboratories at the Department of Pharmacy. His research activity deals with Food Chemistry and Nutraceutical Sciences. The results from his studies have been the object of 80 scientific publications on international journals with impact factor.
Abstract:
Nutraceuticals define a new category which shades the frontier between drugs and food. As per its definition, a nutraceutical is “a food or part of a food that provides benefits health in addition to its nutritional content”. Active substances either way extracted from plants (phytocomplexes) or of animal origin, when extracted, concentrated and administered in a suitable pharmaceutical form, can create a very promising toolbox useful to prevent and/or support the therapy of some pathologic conditions given their proven clinical efficacy. It is worldwide recognized that diet and lifestyle are essential to promote and maintain well-being and nice-being condition, other than help to prevent diseases possible onset. Both non-correct dietary habits and lifestyle can in fact determine pathological conditions. The metabolic syndrome, a worldwide epidemic threat, can be named an outstanding example. This syndrome is characterized by a cascade of cardio metabolic risk factors which include obesity, insulin resistance, hypertension, and dyslipidemia. Prevention is the key strategy for an effective proactive medicine, in which efforts are addressed to prevention and, consequently, to lower the risk connected to some lifestyle related diseases reducing, at the same time, any National Health Systems cost needed to guarantee the proper therapeutic approach based on pharmaceuticals. Nutraceuticals use in prevention is a proactive reverse approach tool to preclinical health conditions. They can be effectively used, by including in the daily diet, in an area which shades in the range “beyond the diet, before drugs”, since they combine both nutritional and beneficial healthy properties of food extracts with the healing properties of natural active compounds
- Nutraceuticals for Cancer Therapy | Dietary Supplements & Functional Foods | Weight Supplements | Bioactive Nutraceuticals | Nutrition, Obesity and Diabetes | Diabetes Nutrition | Parenteral Nutrition | Public Health Nutrition | Nutrition and Cardiovascular Health
Location: Olimpica (3+4)
Chair
Moses S S Chow
Western University of Health Sciences, USA
Co-Chair
Roni L Moya
CESPU University, Portugal
Session Introduction
Roni Lara Moya
CESPU University, Portugal
Title: Biomedical integrative approach to oncology from “Vitamins to Cellular Therapy
Biography:
Roni Lara Moya completed his Bachelor’s in Biomedicine from University of Mogi das Cruzes, Sao Paulo and a Specialization in Anti-Aging Medicine from Seville University, Spain. He completed Master of Science in Molecular and Cellular Immunology and Biology in University of Coimbra, Portugal and a Master of Science degree in Clinical Advanced Nutrition, University of Barcelona, Spain and PhD in Biomedicine and Immunology, Gulbenkian Institute of Science and Coimbra University. He is a Coordinator of Orthomolecular Medicine of ReGenera Research Group for Aging Intervention. He is a Professor and Director of the Graduation Program in Orthomolecular Therapy, CESPU University, Portugal and Scientific Advisor for Nutraceuticals and Cell Therapy Companies in Europe
Abstract:
Despite all efforts and scientific development in cancer research and treatments, the corresponding estimates for total cancer deaths in 2012 were 8.2 million (about 22,000 cancer deaths a day) – 2.9 million in economically developed countries, and 5.3 million in economically developing countries. By 2030, the global burden is expected to grow to 23.6 million new cancer cases and 13 million cancer deaths imply due to the growth and aging of the population. However, the estimated future cancer burden will probably be considerably larger due to the adoption of lifestyles that are known to increase cancer risk, such as smoking, poor diet, obesity, physical inactivity, chronic inflammatory diseases, etc. Cancer can actually be defined by a group of diseases characterized by the interaction between abnormal cells with its natural environment, resulting in uncontrolled growth and spread of these abnormal cells. If the spread is not controlled, it can result in death. Cancer is caused by external factors, such as tobacco, toxins, infectious organisms, an unhealthy diet, and internal factors, such as inherited genetic mutations, hormones, and immune conditions, may act together or in sequence to cause cancer. One of the most important problems in oncology is the immunological compromising due to the ability of cancer cells to thrive in a chronically inflamed microenvironment, evade immune recognition and suppress immune reactivity. In consequence, the chronic inflammation and extreme oxidative stress, will allow an enhancement of genomic instability, DNA damage, epigenetics change, apoptosis evasion, metastasis, etc. Some important functional nutrients with specific antioxidants and polyphenols, together with purified cellular derived peptides and mitochondrial extracts, rich in inmunomodulator factors, work on innate or acquired immunity. They stimulate fundamental organs as the thymus, spleen and bone marrow, regulating the transcription, apoptosis, oxidative stress, the activation of dendritic cell, B lymphocytes CD4, CD8, and Natural Killer (NK); as well as the production of its main cytokines (IFN, T NF, IL4, etc.). The purpose of this conference is to address the clinical practical aspects and protocols based on the most relevant scientific studies of integrative biomedical treatments with the best functional nutrients and cellular derived extracts as potent inmunomodulators in cancer cases. Besides the increase in conventional treatment techniques and pharmaceuticals, there is also an eminent and continuous need to seek the best and smartest integrative biomedical and nutritional treatment to help prevent and fight cancer
Vivienne Lewis
University of Canberra, Australia
Title: Working with people with body image issues and eating disorders. A guide to health professionals
Biography:
Vivienne Lewis is a Clinical Psychologist, specialising in the area of body image and eating disorders both in her clinical practice and in her research at the University of Canberra, Australia. She is the author of “Positive Bodies: Loving The Skin You’re In” a self-help book for people, including both men and women, with body image issues. She also recently released a guide for health profressionals working with people with body image issues and eating disorders called ‘No Body’s Perfect’. Both of these books are published through Australian Academic Press. She is actively involved with many government eating disorder and body image services promoting the celerbation of body acceptance and diversity. She is a Committee Member for the professional body, the Australian Psychological Society College of Clinical Psychologists
Abstract:
Body image satisfaction is important, particularly for females, in terms of positive mental health. A healthy body is part of a health body image and perception of self. We know that a poor body image is a key diagnostic criterion for eating disorders and is related to engagement in eating disordered behaviour and poorer mental health. Working with people with body image issues and eating disorders is complex and sensitivity is needed. Eating disorders are severe and complex conditions that often require expertise in order to work effectively with this client group. This presentation is a guide to health profressionals, including dieticians and nutritionists as to how to work with adults presenting with body image issues and eating disorders. The author will draw on her experience as a researcher and clinican having worked with many people of all ages and both genders presenting to her as a clinical psychologist
Silvia Martina Ferrari
University of Pisa, Italy
Title: Myo-inositol in thyroid autoimmune disorders
Biography:
Silvia Martina Ferrari graduated in Biological Sciences cum laude in 2002 and specialized in Clinical Pathology in 2007 at the University of Pisa (Italy). Her principal areas of expertise are autoimmune thyroid disorders, chemokines and cytokines, type 1 diabetes, systemic autoimmune disorders, HCV-associated thyroid disorders and thyroid cancer. Her researches have been published in more than 140 articles in international journals (HI=37). She serves as an Editorial Board Member and is Referee and Reviewer of many scientific international journals
Abstract:
Myo-inositol has a determinant role in different metabolic pathways. Experimental data and clinical trials showed that myo-inositol and phosphatidylinositol(s) are involved in physiological and pathological conditions of the thyroid. Phosphatidylinositol is important in the intracellular signaling associated with thyroid-stimulating hormone (TSH) pathway in thyrocytes, and it is involved in thyroid autoimmunity. Recently it has been demonstrated the beneficial effects obtained by myo-inositol in association with seleno-methionine in patients affected by subclinical hypothyroidism. The myo-inositol effectiveness on TSH could be explained by its biological role in the TSH hormone signaling, as inositol regulates the H2O2-mediated iodination and the impairment of inositol-depended TSH signaling pathway can cause TSH resistance, and hypothyroidism. For this reason, the therapy can increase the amount of the second messenger, improving the TSH sensitivity. Moreover, it seems that myo-inositol could have promising therapeutic effects in insulin resistance, metabolic syndrome and their related disorders [diabetes, polycystic ovary syndrome (PCOS)], autoimmunity and certain malignancies, and their links. Further studies on the inositol pathways involved in certain disorders could lead to hypothesize additional therapeutic applications
Lujain Abdulaziz Almousa
The University of Nottingham, UK
Title: Effect of varying magnesium concentrations on NF-kB gene expression in Human Umbilical Vein Endothelial Cells (HUVECs)
Biography:
L A Almousa has completed her Doctorate program in Human Nutrition from College of Food & Agricultural – King Saud University in 2012, Master’s in General Nutrition from Prince Nora University in 2007 and Bachelor’s degree in Nutrition and Food Science, Prince Nora University in 2002. At present, she is studying for a PhD degree at the University of Nottingham (UK)
Abstract:
Magnesium has anti-inflammatory and antioxidant effects, and it has a defensive role in triggering the body’s immune cells. Moreover, magnesium enhances endothelial function and inhibits atherosclerosis. Inflammation is a risk factor for atherosclerosis progression and can be mediated by nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) activation, which plays a key role in the development of inflammation because when NF-κB transfers to the nucleus and binds to promoter regions, it initiates the transcription of many inflammatory mediators. In response to inflammation, NF-κB enhances the transcription of Intercellular Adhesion Molecule-1 (ICAM-1), Vascular Cell Adhesion Molecule-1 (VCAM1) and inflammatory cytokines, which aid in the transmigration of leukocytes from the blood vessel lumen through the barrier of the endothelial cells and into the subendothelial space. In this study we determined the effect of different concentrations of magnesium on the expression of NF-κB. HUVECs were cultured in different MgSO4 concentrations: 0.1 mM, 5 mM and compared to the physiological circulating concentration (1 mM). Expression of NF-κB was determined at the mRNA level by quantitative real-time PCR. Significantly elevated NF-κB expression was observed in magnesium-deficient (0.1 mM) cells that were stimulated with lipopolysaccharide 0.5 µg for 4 hours (34%, P=0.032), Moreover, a marked suppression of NF-κB expression in the magnesium-treated (5 mM), LPS stimulated HUVECs was observed (31%, P=0.048), relative to the 1 mM physiological concentration. These data shows that magnesium was inversely associated with the expression of NF-κB which induces an overexpression of the inflammatory phenotype in endothelial cells and has been connected to the pathogenesis of many cardiovascular diseases
Biography:
Poupak Fallahi graduated in Medicine and Surgery in 1993 and specialized in Occupational Health Medicine in 1999 at the University of Pisa (Italy). Her principal areas of expertise are autoimmune thyroid disorders, Type 1 diabetes, chemokines and cytokines, systemic autoimmune disorders, HCV-associated thyroid disorders and thyroid cancer. Her researches have been published in more than 200 articles on International journals (HI=46). She serves as an editorial board member and is Referee and Reviewer of many scientific International journals
Abstract:
Different human diseases, as cancer, impaired immune function, neurodegenerative and age-related disorders and disturbances of the thyroid hormone axis, are related to an insufficient supply of the essential trace element selenium. For example, its deficiency, in combination with inadequate iodine, is involved in the pathogenesis of myxedematous cretinism. Selenium naturally occurs in an inorganic (mineral or metallic) or organic form (selenomethionine and selenocysteine), and its biological action is exerted through selenoproteins. The thyroid gland has the highest selenium content per gram of tissue of the whole body. in cellular antioxidative defence systems and redox control [the glutathione peroxidase (GPx) and the thioredoxin reductase (TxnRd) family] contribute in protecting the thyroid from an excess of hydrogen peroxide and reactive oxygen species, derived from the biosynthesis of thyroid hormones. Moreover, the three major enzymes involved in activation and inactivation of thyroid hormones are selenoproteins. Serum selenium concentrations decrease in inflammatory conditions and can vary according to the severity and duration of the inflammation. For this reason, the effect of selenium supplementation seems to be useful. Moreover, selenium is able to improve the activity of T cells and the cytotoxicity of natural killer cells, resulting efficacious in viral diseases. However, whether selenium supplementation is effective in patients with Hashimoto Thyroiditis is still not clear, even if it seems advantageous in cases of mild/moderate Graves’ Orbitopathy. In conclusion, further studies are necessary to evaluate whether selenium supplementation could be effective in autoimmune thyroid disorders
Stefania D’Adamo
University of Bologna, Italy
Title: Emerging nutraceuticals in the management of osteoarthritis: Focus on 3-hydroxytyrosol in epigenetics and autophagy pathway
Biography:
Stefania D’Adamo is a Molecular Biologist and Post-Doctoral Fellow in Flamigni’s Lab at University of Bologna working on nutraceutical role in the modulation of some dysregulated pathways implicated in chronic and degenerative pathologies, including cardiovascular and osteoarthritis diseases. She has opened a new research line in her lab that focuses on exploring the epigenetic connections between nutraceuticals and defective processes associated to aging
Abstract:
Osteoarthritis (OA) is the most frequent degenerative pathology of joints leading to pain and loss of function for many patients, in particular the elders. Aging has been proposed as the main risk factor of this pathology, followed by obesity. The real hub between aging changes in cells and proneness to OA seems to be found in the role of cell senescence. This phenotype can be associated to an over production of reactive oxygen species (ROS) due to defective mitochondrial function and up-regulation of inflammatory pathways that participate in the “aging stress response”. However lack of efficacy in current pharmacotherapy is spurring scientific community to spend efforts and resources to unveil new molecular targets and alternative therapies. Nutraceuticals have been shown to exhibit a role not merely as anti-oxidant or ROS scavengers, but also as efficient modulators of gene expression of key factors underlying the OA onset. The most commonly used dietary supplements and the recent scientific evidence on novel natural compounds supporting the efficacy for OA treatment and prevention will be discussed. In particular, I will pay attention to a promising nutraceutical, 3- hydroxytyrosol (HT). It is a phenolic compound, endowed of a powerful anti-oxidant action, mainly found in the fruits of olive tree (Olea europaea L.) and their derivatives, such as olive oil. Our recent findings have shown HT as a potent promoter of autophagy flux and autophagy-related gene expression. Then, we demonstrated that HT can modulate the longevity factor Sirt1, by modulating microRNA (miR) network. The image on the right represents the molecular mechanisms by which HT can exert protection against oxidative stress-induced cell death in chondrocytes. This evidence suggests that HT can be considered in the future as an adjuvant nutraceutical in OA therapy
Carla Sillitti
University of Foggia, Italy
Title: Use of sicilian ancient durum wheat for the production of low-GI spaghetti
Biography:
Carla Sillitti is a PhD student of the University of Foggia. She is carrying out her PhD work in collaboration with CNR-ISAFOM in Catania. She has completed her Master’s in Health Biology. She is developing a project to produce new nutraceutical food, a type of pasta, based on the use of ancient Sicilian whole meal and inulin. Many studies were carried out to define the best type of semolina and inulin to be added. She is interested in nutraceutical food and food quality, as well as nutrition and human health
Abstract:
Statement of the Problem: The ancient Sicilian whole meal grains, re-evaluated as the basis of the Mediterranean diet, are rich in fiber and vitamins and matched the inulin consumption contribute to lower the glycemic index of pasta produced, representing a good source of carbohydrates for diabetics. Currently the inulin added to foods is extracted from chicory (~20 fructose units). The aim of the study was to evaluate the quality of pasta obtained by ancient Sicilian whole grains semolina with inulin extracted from roots of cardoon (~80 fructose units).
Methodology & Theoretical Orientation: Four cvs of whole meal flour durum wheat (Russello, Senatore Cappelli, Margherito and Timilia) were used for the production of spaghetti with 2 types of inulin extracted from roots of both chicory and cardoon, in 2 and 4% (w/w). A commercial durum wheat semolina was used as a control. Pastas produced were evaluated for color (Minolta colorimeter CR, 400), cooking time (minutes), quality and loss of inulin (HPAEC-PAD, Thermofisher) in cooking and sensory qualities (Panel).
Findings: On average of 4 varieties, the overall quality of the spaghetti was 6.5 compared with 5.9 of the control. The values increased with the addition of 2% (w/w) of inulin, in fact the cv “Russello” and “Senatore Cappelli” showed values of 6.8 and 6.6 respectively, compared with the control (6.5). With the highest concentration of inulin showed highest interaction with the cv used. “Margherito”, “Timilia” and “Senatore Cappelli” showed higher values with cardoon inulin, although “Russello” and “Senatore Cappelli” decreased their values with the addition of chicory inulin. On average of 4 varieties, the addition of inulin from cardoon resulted in an increase in the index L*, perceived positively during the panel test. Different types of semolina have influenced mainly the cooking loss.
Conclusion & Significance: Further tests are underway to define the optimal concentration of inulin to add and the best type of semolina to use
Kimia Moiniafshari
Islamic Azad University, Iran
Title: The effect of vitamin D and Omega-3 fatty acids supplementation on athlete's metabolism
Time : 15:30-15:50
Biography:
Kimia Moiniafshari has received her BSc degree in Nutrition field from Shahid Beheshti University of Medical Sciences and is MSc student in Sport Nutrition field. She is Nutrition and Autism Researcher and her BSc thesis was about management of nutritional strategies for preventing and controlling autism, and has some publications in this area and now is working on athlete's metabolism and effective supplements for improving their exercise performance
Abstract:
Vitamin D deficiency is common among athletes depending on their skin color and indoor exercise time. Vitamin D is a vital component in biological reactions in human. Scientific articles have shown that vitamin D supplementation has positive effects on athletes’ performance. Besides that, omega-3 fatty acids (FA) play supportive role on athlete's cardio-vascular system. The purpose of this review article was to evaluate the effect of vitamin D and omega-3 FA supplementation on muscles, aerobic capacity, exercise performance and cardio-vascular system in athletes. Among the total 40 articles including entrance criteria, 19 articles including 13 original and 6 review articles were analyzed. Vitamin D plays important roles in synthesis of proteins, hormones, gene expression regulation and muscular performance. Vitamin D deficiency increases the risk of fractures, inflammation, infection and prolonged recovery time. Furthermore, vitamin D increases calcium availability and improves cross bridge cycle and muscular contractions. Decreased level of vitamin D lower than 30 nmol/lit leads to reduced exercise power and increases the risk of infections, Omega-3 FAs improves cardio-vascular function via nitric oxide production and also leads to less total oxygen consumption, lower heart rate and muscular oxygen requirement. Researchers have suggested that omega-3 Fas supplementation increases the level of ecosapanthanoic acid (EPA) in erythrocytes and decreases the peroxidative erythrocyte's protein destruction which results in oxidative balance. Vitamin D and omega-3 Fas supplementation have beneficial effects on athletes’ performance and doses higher than physiological daily intake may be needed according to increased requirement and deficiency prevalence in athletes